logo

SI

Shoulder Innovations·NYSE
--
--(--)
--
--(--)

SI fundamentals

Shoulder Innovations (SI) released its earnings on Mar 10, 2026: revenue was 14.42M (YoY --), beat estimates; EPS was -0.38 (YoY --), beat estimates.
Revenue / YoY
14.42M
--
EPS / YoY
-0.38
--
Report date
Mar 10, 2026
SI Earnings Call Summary for Q4,2025
  • Revenue Surge: Q4 2025 revenue up 65% YoY to $14.4M, full-year $47.3M (50% YoY), driven by 61% growth in core/contender surgeons.
  • Robotics Breakthrough: Portable micro-robotics partnership enables ASC adoption, with 0 workflow change and 100% ProVoyance integration.
  • Product Expansion: I-135RFX and N-22 in limited release, targeting 100% case coverage with higher ASPs.
  • 2026 Guidance: $62-65M revenue (31-37% YoY), stable margins with late-year gross margin improvements.
  • ASC Leadership: 30% of procedures in ASCs vs. 15% industry, enabled by ASC-optimized instrumentation.
EPS
Q2,2025
Q3,2025
Q4,2025
Actual
-165.53-0.64-0.38
Forecast
-0.6301-0.3134-0.3854
Surprise
-26170.43%
-104.21%
+1.40%
Revenue
Q2,2025
Q3,2025
Q4,2025
Actual
11.01M11.76M14.42M
Forecast
11.00M9.87M12.79M
Surprise
+0.10%
+19.10%
+12.69%

Earnings Call